Enveric raises $2.2M in warrant exercise inducement; issues new Series C/D warrants

Enveric Biosciences, Inc.

Holders exercised 1,212,499 Series A and 1,212,499 Series B warrants at reduced price of $0.915/share.
Gross proceeds ~$2.2M; H.C. Wainwright acted as placement agent (7% fee).
Company issued new unregistered Series C (2,424,998 shares, 5-yr term) and Series D (2,424,998 shares, 18-mo term) warrants at $0.915.
New warrants exercisable only after stockholder approval; proceeds for working capital and product development.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.